The predictive value of inflammation-related peripheral blood measurements in cancer staging and prognosis

Joanna L. Sylman, Annachiara Mitrugno, Michelle Atallah, Garth W. Tormoen, Joseph J. Shatzel, Samuel Tassi Yunga, Todd H. Wagner, John T. Leppert, Parag Mallick, Owen McCarty

Research output: Contribution to journalReview article

6 Scopus citations

Abstract

In this review, we discuss the interaction between cancer and markers of inflammation (such as levels of inflammatory cells and proteins) in the circulation, and the potential benefits of routinely monitoring these markers in peripheral blood measurement assays. Next, we discuss the prognostic value and limitations of using inflammatory markers such as neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and C-reactive protein measurements. Furthermore, the review discusses the benefits of combining multiple types of measurements and longitudinal tracking to improve staging and prognosis prediction of patients with cancer, and the ability of novel in silico frameworks to leverage this high-dimensional data.

Original languageEnglish (US)
Article number78
JournalFrontiers in Oncology
Volume8
Issue numberMAR
DOIs
StatePublished - Mar 21 2018

    Fingerprint

Keywords

  • Biomarkers
  • C-reactive protein
  • Cancer
  • Longitudinal
  • Neutrophil-to-lymphocyte
  • Platelet-to-lymphocyte
  • Prognosis

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Sylman, J. L., Mitrugno, A., Atallah, M., Tormoen, G. W., Shatzel, J. J., Yunga, S. T., Wagner, T. H., Leppert, J. T., Mallick, P., & McCarty, O. (2018). The predictive value of inflammation-related peripheral blood measurements in cancer staging and prognosis. Frontiers in Oncology, 8(MAR), [78]. https://doi.org/10.3389/fonc.2018.00078